×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: Coronavirus | Infrastructure | Money | Vaccines | Merck

Merck Projects Full-Year Revenue up to $47.9 Billion

Merck Projects Full-Year Revenue up to $47.9 Billion

Thursday, 28 October 2021 07:03 AM

Merck & Co. (MRK) Thursday reported third-quarter profit of $4.57 billion.

The Kenilworth, New Jersey-based company said it had net income of $1.80 per share. Earnings, adjusted for one-time gains and costs, came to $1.75 per share.

The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.54 per share.

The pharmaceutical company posted revenue of $13.15 billion in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $12.42 billion.

Merck expects full-year earnings in the range of $5.65 to $5.70 per share, with revenue in the range of $47.4 billion to $47.9 billion.

© Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


StreetTalk
Merck & Co. (MRK) Thursday reported third-quarter profit of $4.57 billion.The Kenilworth, New Jersey-based company said it had net income of $1.80 per share. Earnings, adjusted for one-time gains and costs, came to $1.75 per share.
Merck
111
2021-03-28
Thursday, 28 October 2021 07:03 AM
Newsmax Media, Inc.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved